Overview

Oncology Nursing Society Symposium

Indy Hematology Education, Inc. is partnering with the Oncology Nursing Society chapters to provide increased nursing education statewide. As a result, Indy Hematology Education, Inc. is planning an inaugural Indiana Oncology Nursing Society Symposium focusing on nursing education and the health of the nursing team to achieve improved patient outcomes.

Rare Diseases Symposium

Rare diseases frequently treated in the community can pose a major challenge to treating physicians, advanced practitioners, and nurses. Additionally, there is sometimes a lack of consensus criteria for the management of these disorders. The rarity of the disease states further exacerbates these issues; therefore, there are infrequent presentations to treating physicians who have difficulty establishing significant expertise in treating these rare conditions. However, despite the rarity of these diseases, most patients are treated in the community. Thus, the education of providers in community practice is imperative and warranted to promote a better understanding of the diagnosis, treatment, and emerging therapeutics for the management of these disorders.

Learning Objectives

Oncology Nursing Society Symposium

1. Evaluate the best strategies to support patients with oncologic emergencies.

2. Discuss current oral oncolytic agents and know how to support cancer patients who are on these therapies.

3. Identify the optimal strategies to support cancer patients within the Integrative Cancer Care environment.

4. Review strategies to avoid or manage burnout while supporting cancer patients and ensuring optimal patient care.

5. Effectively navigate difficult conversations with their cancer patients.

6. Identify which patients might benefit from art therapy and know how to connect cancer patients with art therapy resources.

7. Discuss how to support cancer patients during the implementation of precision medicine in clinical practice.

Rare Diseases Symposium

1. Implement strategies to treat and manage patients with rare cancers in community Oncology practices.

2. Discuss current the best practices in interpreting NGS results in the management of Acute Leukemias, Mastocytosis and Lympohomas.

3. Identify the optimal strategies to effectively manage Leukemia patients who are not eligible for intensive chemotherapy and small molecule targeted therapy in community oncology settings.

4. Review the best treatment options for managing patients with Acute Lymphoblastic Leukemia including Monoclonal Antibodies and targeted therapies.

5. Effectively implement optimal treatment strategies for patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

6. Apply optimal management strategies for patients with T-Cell Lymphomas / Leukemias

7. Implement management strategies for patients with Cold Agglutinin Disease, Thrombotic Thrombocytopenic Purpura and Paroxysmal Nocturnal Hemoglobinuria

8. Discuss optimal strategies for on recognizing, diagnosing and treating patients with Hemophagocytic Lymphohistiocytosis

9. Review best practices and strategies for recognizing and managing patients with Porphyrias and Systemic Mastocytosis.

10. Apply optimal treatment strategies when managing patients with Rare Plasma Cell Dyscrasias including Monoclonal Gammopathy of Renal Significance, POEMS Syndrome and Amyloidosis.

11. Discuss best practices in leveraging molecular pathology to treat patients with rare cancers

12. Implement optimal treatment strategies when using immunotherapy and targeted therapy in the management of patients with DRIVER mutations and Small Cell Lung Cancer.

13. Effectively apply a “Tumor Agnostic” approach when treating rare cancer patients.

For more information please visit the official event page.